This presentation by Dr Nicola Carey looks at the context of non-medical prescribing in the UK as well as its benefits and challenges.
It was presented at the MS Trust Annual Conference in November 2014.
Making a difference - the benefits and challenges of non-medical prescribingMS Trust
This presentation by Nikki Embrey from the North Midland MS Service looks at the benefits of and barriers to nurse prescribing, and whether it can make a difference to patient outcomes.
It was presented at the MS Trust Annual Conference in November 2014.
Making a difference - the benefits and challenges of non-medical prescribingMS Trust
This presentation by Nikki Embrey from the North Midland MS Service looks at the benefits of and barriers to nurse prescribing, and whether it can make a difference to patient outcomes.
It was presented at the MS Trust Annual Conference in November 2014.
Care in hospital settings is all about the care which is provided in the hospital to the patient. The word patient comes from the Latin word patiens, originally meant “one who suffers”. Care in hospital is the attention or watchful oversight and attentive assistance or treatment for the increasing proportion of population and with the shift in disease patterns from acute illnesses to chronic...
Palliative Care Across the Continuum as presented to the The Palliative Care Summit for PeopleFirst Homecare and Hospice that was held in Snowbird Utah on September 15, 2012, following the Rocky Mountain Geriatric Conference.
palliative care presented by sambu cheruiyot clinical nutritionist in kapkate...cheruiyot sambu
currently we need to understand the role of palliative care in our patients. kapkatet hospital have strongly participated in provision of palliative services. come and witness the strong team willing to help the community.
Advance care planning: "Let's get talking"MS Trust
This presentation by Dr Jo Poultney, Dr Sarah MacLaran, and Dr Julia Grant looks at advance care planning and how to support patients to express their preferences about care: what they do and don't want to happen and the people important to them.
It was presented at the MS Trust Annual Conference in November 2014.
Palliative Care What Is Palliative MedicineIndranil Khan
What is Palliative Care Who needs Palliative Care Components of Palliative Care Doctors in Kolkata West Bengal India Pain Treatment Yoga Morphine Buprenorphine
Ethical issues in medicine and research:Special reference to IndiaJishnu Lalu
A detailed discussion on Ethical consideration concerning physician, patient, co-workers and research. It also discusses publication ethics and Ethics in India
Shelagh Morris, Allied Health Professions Officer of the Department of Health, talks about supplementary prescription. COT Annual Conference 2010 (22-25 June 2010)
Non medical prescribing in multiple sclerosis: where does it fit into practiceMS Trust
This presentation by Linda Renfrew looks at evidence for non medical prescribing among allied health professionals, and how prescribing can be integrated into MS physiotherapy practice.
It was presented at the MS Trust Annual Conference in November 2014.
Care in hospital settings is all about the care which is provided in the hospital to the patient. The word patient comes from the Latin word patiens, originally meant “one who suffers”. Care in hospital is the attention or watchful oversight and attentive assistance or treatment for the increasing proportion of population and with the shift in disease patterns from acute illnesses to chronic...
Palliative Care Across the Continuum as presented to the The Palliative Care Summit for PeopleFirst Homecare and Hospice that was held in Snowbird Utah on September 15, 2012, following the Rocky Mountain Geriatric Conference.
palliative care presented by sambu cheruiyot clinical nutritionist in kapkate...cheruiyot sambu
currently we need to understand the role of palliative care in our patients. kapkatet hospital have strongly participated in provision of palliative services. come and witness the strong team willing to help the community.
Advance care planning: "Let's get talking"MS Trust
This presentation by Dr Jo Poultney, Dr Sarah MacLaran, and Dr Julia Grant looks at advance care planning and how to support patients to express their preferences about care: what they do and don't want to happen and the people important to them.
It was presented at the MS Trust Annual Conference in November 2014.
Palliative Care What Is Palliative MedicineIndranil Khan
What is Palliative Care Who needs Palliative Care Components of Palliative Care Doctors in Kolkata West Bengal India Pain Treatment Yoga Morphine Buprenorphine
Ethical issues in medicine and research:Special reference to IndiaJishnu Lalu
A detailed discussion on Ethical consideration concerning physician, patient, co-workers and research. It also discusses publication ethics and Ethics in India
Shelagh Morris, Allied Health Professions Officer of the Department of Health, talks about supplementary prescription. COT Annual Conference 2010 (22-25 June 2010)
Non medical prescribing in multiple sclerosis: where does it fit into practiceMS Trust
This presentation by Linda Renfrew looks at evidence for non medical prescribing among allied health professionals, and how prescribing can be integrated into MS physiotherapy practice.
It was presented at the MS Trust Annual Conference in November 2014.
Exploring the transition to secondary progressive MS (SPMS): patient, carer a...MS Trust
This presentation by Professor Adrian Edwards and Dr Freya Davies from the Institute of Primary Care and Public Health at Cardiff University looks at the experiences of patients, carers and clinicians at the stage of transition to SPMS.
It was presented at the MS Trust Annual Conference in November 2014.
Prescribing, administration and supply of medicines by allied health professi...MS Trust
This presentation by Helen Marriott, AHP Medicines Project Lead, looks at prescribing and medicines supply mechanisms and the AHP Medicines Project.
It was presented at the MS Trust Annual Conference in November 2014.
How to Make Awesome SlideShares: Tips & TricksSlideShare
Turbocharge your online presence with SlideShare. We provide the best tips and tricks for succeeding on SlideShare. Get ideas for what to upload, tips for designing your deck and more.
Hospice care and palliative care: Is there a difference between the two, and if so, what?
Many people still think that palliative care means hospice care. But today, hospice is only a small part of palliative care.
The goal of palliative care is to prevent or treat the symptoms and side effects of a disease; and it should be part of the picture from the first day a serious illness is diagnosed.
Dr. Jim Meadows, Director of Hospice and Palliative Care at Tennessee Oncology, will discuss this important topic. How does a family and a health care team best work together to guide a patient through a terminal illness? How does everyone continue to support quality, patient-centered, end-of-life care?
I didn't know this option of Palliative care existed prior to my mother's passing earlier this year of colorectal cancer. However, I do now know about it and want to share it with all of you
Purpose of the Call:
Women's College Hospital is an academic ambulatory hospital. The speaker will share their hospital’s journey as they sought to implement best practices for medication reconciliation from other settings customized for the ambulatory environment.
Read more and watch the webinar recording: http://bit.ly/1sxHIUP
MedicalResearch.com: Exclusive Interviews with Medical Research and Health Care Researchers from Major and Specialty Medical Research Journals and Meetings
Current State of Pain Management Services in Primary Care in the UKepicyclops
This lecture was given by Dr Martin Johnson, a General Practitioner from Barnsley, Yorkshire, to the North British Pain Association Spring Scientific Meeting in Edinburgh on Friday 18th May, 2007. This lecture forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
www.wspg.org.uk
Learning outcome 1The chronicity of COPD allows for self manage.docxaryan532920
Learning outcome 1
The chronicity of COPD allows for self management by sufferers. (Spencer & Barcomb 2014). The self management goal is reduced hospital admissions and improved life quality (Bedra et al 2013). Sufferers should have access to a wide range of skills available from the multidisciplinary team. Those include exacerbation limitation, respiratory failure, chronic productive cough and anxiety and depression.
Symptom Recognition.
Patients discharged from hospital are susceptible to readmission (Bedra et al 2013). Understanding the condition and knowing when they are having an exacerbation is imperative for self management, and what to do in the given circumstances, and when and what medication to take, or realise they need hospital treatment.
Treatment.
The main form of treatments comes from inhaled therapies and explained below would be when they would be administered and their understandings are a major factor in self management.
For breathlessness and exercise limitations: A short acting Beta2 agonist (as required) or short acting muscarinic antagonist (as required).
For exacerbations or persistent breathlessness: A long acting beta2 agonist, long acting muscarinic antagonist, to – long acting beta2 agonist + inhaled corticosteroid (Combination Inhaler) OR a long acting muscarinic antagonist (must discontinue short acting antagonist once this is commenced).
(Remember if using Corticosteroids, this has no evidence of long terms benefits).
If experiencing persistent exacerbations or breathlessness. Long acting Muscarinic antagonist + long acting beta2 agonist and inhaled corticosteroid (combined inhaler).
Niesters et al, (2012) describe how oxygen therapy can also be used, but awareness of inappropriate oxygen therapy with COPD patients is imperative as this can cause respiratory depression.
Self Monitoring.
The British Thoracic Society (BTS) have identified five high impact actions that can improve outcomes for people being discharged after an acute exacerbation of COPD. The form is a quick way of identifying patients need for those interventions, ensuring their needs are met. The aim is for lessened hospital readmission rates with self monitoring patients. The five actions are;
Review of medication and demonstration of inhalers they will be using.
Provide a written Self Management plan and Emergency drug pack.
Asses and offer referral for smoking sensation.
Assess for suitability for pulmonary rehab.
Arrange a follow up call within 72 hours of discharge.
Educational Interventions.
Reardon et al, (2005) explain pulmonary rehabilitation as programs which work with patients to help manage their condition, muscle strength, ability to cope with their disease, help with social requirements as people can become quite isolated.
Test includes incremental shuttle walk a 10 metre course, consecutive runs, each time getting faster, measured how far they got, will give idea of what they can endure on the exercise programme th ...
Interventions to change providers' practice in cameroon h hopkinsACT Consortium
Presentation by Heidi Hopkins
Cross-cutting analysis Lead, ACT Consortium
Senior Lecturer in Malaria & Diagnostics at London School of Hygiene & Tropical Medicine
When is it time for a new cancer treatment, and how should patients make these difficult decisions? Rachel Yung, MD, provides an overview of what to consider when making difficult treatment choices.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Making a difference: the benefits and challenges of non-medical prescribing
1. Making a difference:
The benefits and challenges of non-medical prescribing
Dr Nicola Carey
n.carey@surrey.ac.uk
School of Health Sciences
November 2014
Date: Friday 24th October 2014 1
3. Nurse prescribing around the world
New Zealand
Botswana
Canada
Hong Kong
Ireland
Netherlands
South
Africa
Spain ?
Sweden, Norway
Uganda Thailand
USA
Australia
UK
(International Council for Nurses, 2009)
Finland
4. Quiz
4
1. Which of the following groups have prescribing rights in England?
Nurses & midwives Podiatrists Paramedics Physiotherapists
Dieticians Optometrists Radiographers Pharmacists
2. A community Practitioner Nurse Prescriber can only prescribe using
‘Supplementary prescribing’
TRUE? FALSE?
5. Non-medical prescribing in the UK
Community practitioner prescriber (District nurse, health
visitor, community nurse or school nurse)
• Approx 36,300
• Mainly appliances, dressings, P and GSL medicines and 13 POMs
Nurse Independent Supplementary Prescribers (NISP)
• Any first level registered nurse
• Over 28,000
Other healthcare professional prescribers
– 4,175 Pharmacists (independent/supplementary prescribers)
– Podiatrists (380) and Physiotherapists (568) supplementary
prescribers
– Optometrists (number not known) and radiographers (38)
supplementary prescribers
(Source: ANP conference 2013)
5
6. The context of NMP in England
6
Settings and areas of prescribing
8. Quiz
8
Where do you think the majority of NMPs are based?
Primary care Secondary care
9. Where are NMPs based?
9
• Majority based in primary care
• Number of NISP in secondary care is increasing
Data from one SHA (Courtenay et al. 2012)
10. Quiz
10
What do you think is the average reported number of items prescribed per week
by nurses?
1-10 20-30 40-50
11. Variation in prescribing frequency
11
Pain medication: estimated number of items prescribed per week by
UK nurses in inpatient pain services (Stenner et al. 2011)
35
30
25
20
15
10
5
0
Number of
respondents
Number of items prescribed per typical week
1 to 5 6 to 10 11 to 20 21 to 30 31 to 40 41 to 50 50 plus
number of items
NIP
NSP
12. 12
Trainee NMP Survey
Sample: 140 trainees enrolled on NMP programmes in 4 universities
• 44% secondary care, 40% specialist nurses
• Number of conditions will prescribe for = 1-16 (mean 4.8)
• Anticipated number of prescriptions per week = 1-20 (mean 5.2)
13. Supplementary prescribing
13
Is there a future for supplementary prescribing?
Some trusts require newly qualified prescribers to use SP for the first
year before prescribing independently
Few participants used SP– and those that did were confined by
legislation, local policy or the need to prescribe controlled drugs
(Courtenay et al. 2012)
14. Quiz
14
What percentage of qualified NISPs are currently using their qualification to
prescribe for patients?
under 30% around 50% 60-70% 80+%
15. Use of prescribing once qualified - nurses
15
Initial concern over low use of prescribing once qualified
High use amongst NISPs
– Latter et al (2010), national survey: 86% NISPs currently
prescribe
– Courtenay et al (2012), East England survey: 90% NISPs
currently prescribe
– Main reasons for not prescribing is moving to role where it is
not required
– BUT – volunteer sample
16. Variation in prescribing
16
Frequency of prescribing linked to level of
support, care setting, prior experience
Fewer items prescribed per week by
community practitioner prescribers, mental
health nurses and pharmacists
Courtenay et al. (2012)
Systematic review:
Studies comparing the number and range of medication prescribed by nurses and
doctors show mixed results depending the condition and the type of medication
prescribed (Gielen et al. 2014)
20. Benefits of nurse prescribing
20
• Faster access to medicines
• Better use of nurses’ and doctors’ time
• Care provided is equivalent to that provided by doctors
• High patient satisfaction
• Streamlining services
• Improved autonomy and job satisfaction for nurses
21. Views of nurses
21
“I like to make the decisions with the patients. So we do a lot of
working through the products to find the one that they like, and
the one that they are going to use, and the one that works.
I’m prepared to do that work with them, whereas maybe a doctor
wouldn’t necessarily. I think that really helps because it definitely
reduces the problems with the eczemas if you get them on a
regime that they like.” (Specialist nurse, dermatology. Courtenay et al
2009b)
“It’s just fantastic now that you can say to patients
‘Just bare with me, I’ll be a few minutes we’ll get
this sorted out and we’ll get on top of your pain’.
Whereas before I didn’t feel confident enough to be
able to say that to the patients because I knew all
the frustrations that I was going to have to be able
to get that job done.”
(Pain nurse. Stenner & Courtenay 2008)
22. Views of nurses
22
Prescribing for patients with respiratory conditions
“the biggest thing for patients is the delay in getting
prescriptions, especially when they’re acutely unwell. People
that are not prescribers have to come back at the end of the
day, write a letter on a computer, fax it over to the GP, check
that they’ve got that fax, the GP needs to read and agree
with it and then a prescription gets generated. Sometimes it
takes up to 2 days, whereas if I’ve gone to see them I can
prescribe it there and then.” [Nurse Consultant]
“If they said that we could no longer prescribe, that
would have a huge impact, especially on our client
group. And I would question that people probably
wouldn’t use our services if that they knew that we
couldn’t prescribe.” [Nurse Practitioner]
Carey et al. (2014)
23. Benefits reported by patients
23
Benefits from the style of nurse prescriber
consultations
•Able to ask questions & solve problems
•Health and lifestyle issues are considered
•Information and treatment is tailored to person
•Better able to understand condition & treatment
•Better able to manage condition & treatment
•More confident in treatment
•Increased satisfaction
•Increased wellbeing
24. Views of patients
24
‘Usually I see the nurse, then I have to see the doctor. If the
nurse can prescribe insulins and anything I need like that, then
I think it’s going to cut a lot of time.’
‘‘It is as though it’s been tailored for you rather
than. . .. I mean the last time I asked for a
prescription at my GPs he just spoke to his
computer”
Courtenay et al (2010) , Stenner et al. (2010)
25. Gaps in the evidence base
Little research
evidence of
benefits in
terms of:
patient
outcomes
health
economics
Patients,
nurses,
doctors and
other key
stakeholders
report many
benefits to
nurse
prescribing
26. Research evidence
26
Systematic reviews of nurse prescribing or nurse-led care
Few differences between nurses and doctors in clinical outcomes
Patients are equally satisfied or more satisfied with nurse care
Quality of care indicators are equal or higher for nurse care compared to
doctor care
[Laurant et al. 2004; Bhanbhro et al. 2011; Gielen et al. 2014]
28. Concerns
28
Doctors and other healthcare professionals
• Do NMPs have the necessary training and experience to
prescribe?
• Am I able to trust this NMP? (relationships building)
• Is the NMP aware of their own limitations and able to refer
to doctor when in doubt?
“I would feel very anxious about high-flying
ambitious people who do their
nursing and at very early years to do
this nurse prescribing because, whilst
they may be very able, what they have
not had is the experience, and that is
essential in my mind.”
(Doctor, secondary care. Stenner et al. 2009)
29. Concerns
29
Patients
• Presume that NMP has had the appropriate training
• Prefer that NMPs are experienced in their area of practice
• Can the NMP assess and diagnose to the same level as a doctor?
• Is the NMP aware of their own limitations and able to refer to a
doctor when in doubt?
“I’ve seen other diabetes nurses in the
past and I certainly wouldn’t feel
confident with them prescribing. But if
you’ve got a nurse that is fully clued up
and takes their time to learn as much as
they can, then they are as good, if not
better, than the doctor.” (Patient with diabetes)
30. Trainee NMP survey
30
Top anticipated benefits Top anticipated concerns
• Reduced waiting time for
patients
• Reduced waiting for doctor
• More holistic care
• Fear of litigation
• Gaining confidence
• Conflict of misunderstanding
Confidence
Dobel-ober et al (2013) – use of structured guidance/formulary
promotes adoption of independent prescribing by mental health
nurses
31. Safety challenges
31
Observation of consultations
Studies: Latter et al (2005, 2010), Courtenay et al (2009a, 2009b)
Inconsistent results for:
• Asking patients about use of herbal and over-the-counter
medications
• Explaining the risks, benefits and potential side effects of
treatment
• Improving history taking, assessment & diagnosis
32. Prescribing for dermatological conditions
32
Assessment of consultations between nurse and patient
Assessment of Communication
0 5 10 15 20 25 30 35 40
Listening and understanding
Sensitive to patient concerns
Gives clear instructions
Identifies & plans for future needs
Explains condition, risks & benefits
Helps patient make informed choice
Instructs on side effects
Yes No N/A Disagree
33. Observations
33
Caution when interpreting this data:
• a high number of consultations observed in these studies involved repeat
prescriptions for long-term conditions (e.g. diabetes) where it could be
expected that these issues may previously been addressed. Medications
may also have been initiated by a doctor some time ago.
• High level of disagreement between experts over some variables
Message: don’t presume that these issues have already been
discussed
“There is probably a bit more I could
know about the side effects. Without a
doubt. But there again, I’ve never
asked her.”
(Patient with diabetes)
34. Clinical Governance
34
Key aspects of clinical governance are in place (e.g. access to safety
updates, BNF, specimen signature, agreed scope of practice) but
improvements can be made:
• Access to own prescribing data
• Regular audit of clinical practice
(Courtenay et al. 2012, Latter et al. 2010)
35. Other challenges
35
Safe prescribing for patients with complex conditions, co-morbidities
or on multiple-medications
• More NMPs involved in complex decision making, prescribing in specialist
areas and for more patients with multiple morbidity
• 61.5% NISPs prescribed for complex conditions in their main area of
practice and 58% had concerns about this. Latter et al (2010)
Access to patient records and computer generated prescriptions
• Remote or mobile workers in the community
Other challenges?
37. Project overview
37
Evaluation of physiotherapist and podiatrist independent
prescribing, mixing of medicines and prescribing of controlled drugs
Project web page:
http://www.surrey.ac.uk/fhms/research/healthcarepractice/evaluation_of_physiotherapy.htm
University of Surrey
• Dr Nicola Carey (PI)
• Dr Karen Stenner
• Professor Heather Gage
• Professor Molly Courtenay
Project manager: Dr Freda Mold
Research fellow: Judith Edwards
Statistical adviser: Peter Williams
University of Brighton
• Professor Ann Moore
• Dr Simon Otter
Liverpool John Moores University
• Dr Jane Brown
Project Advisory Group
• Multi-professional membership
• Chaired by June Crown (CBE)
Patient and Public Involvement
group
38. Mixed Method Evaluation
38
Aim: to evaluate the effectiveness and efficiency
of independent prescribing by physiotherapists
and podiatrists
39. Three phases
39
Phases 1 and 2
Methods:
1. Literature review
2. Trainee PP-IP survey, during and post-course
3. Analysis of documentary evidence
Research Questions:
• What types of services do PPs provide?
• Any evidence for the effectiveness of supplementary prescribing?
• How and where is PP independent prescribing going to be used?
• Evaluation of the IP training programme
Phase 3 – Case study
• Any difference in process or outcome indicators?
• Differences in medicines management activities?
• Barriers and facilitators?
• Costs?
40. Case study
40
12 case sites: Independent Prescribers
- 3 podiatrists
- 3 physiotherapists
Non-Prescribers
- 3 podiatrists
- 3 physiotherapists
Data collection methods:
Interviews – Podiatrists,
physiotherapists, wider teams,
managers
Observation – work sampling
and record of medicines management
activities observed over 5 day period
Questionnaires– patient
satisfaction with services, information
about medicines, quality of life
Assessment of
consultations – audio-recorded
consultations (5 per site) assessed by
independent experts
- Assessment of prescriptions using
Medications Appropriateness Index
Audit – patient records (15 per site)
audited for information on service use
2 months post consultation
41. Sources & References
Bhanbhro S. et al. (2011) Assessing the contribution of prescribing in primary care by
nurses and professionals allied to medicine: a systematic review of the literature. BMC
Health Serv.Res. 11, 330
Carey N. Stenner K. & Courtenay M (2014) An exploration of how nurse prescribing is
being used for patients with respiratory conditions across the east of England. BMC
Health Serv. Res. 14, 27.
Courtenay M, Stenner K & Carey N (2010) The views of patients with diabetes about
nurse prescribing. Diabetic medicine, 27, 1049-1054
Courtenay M, Stenner K & Carey N (2009a) An exploration of the practices of nurse
prescribers who care for people with diabetes: a case study. Journal of Nursing and
Healthcare of Chronic Illness, 1, 311-320.
Courtenay M, Carey N & Stenner K (2009b) Nurse prescriber-patient consultations: a
case study in dermatology. Journal of Advanced Nursing, 65 (6), 1207-1217
Courtenay M, Carey N & Stenner K (2012) An overview of non medical prescribing
across one strategic health authority: a questionnaire survey. BMC Health Services
Research, 12, 138.
Dobel-ober D, Bradley E & Brimblecombe N (2013) An evaluation of team and
individual formularies to support independent prescribing in mental health care.
Journal of Psychiatric and Mental Health Nursing, 20, 35-40
Laurant, M. et al. (2004) Substitution of doctors by nurses in primary care. Cochrane
Database of Systematic Reviews (4).
42. Sources continued…
Latter S, Maben J, Myall M, Courtenay M, Young A & Dunn N (2005) An Evaluation of
Extended Formulary Independent Nurse Prescribing. Executive summary of final
report. DoH, London
Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M Gerard K, Little P, Celino N,
Granby T, Nicholls P & Dorer G (2010) Evaluation of nurse and pharmacist
independent prescribing. University of Southampton and Keele University
Stenner K & Courtenay M (2008) Benefits of nurse prescribing for patients in pain:
nurses’ views. Journal of Advanced Nursing, 63 (1), 27-35
Stenner K, Carey N & Courtenay M (2009) Nurse prescribing in dermatology: Doctors’
and non-prescribing nurses’ views. Journal of Advanced Nursing, 65 (4), 851-9
Stenner K, Courtenay M & Carey N (2010) Consultations between nurse prescribers and
patients with diabetes in primary care: a qualitative study of patients views.
International Journal of Nursing Studies, 48, 37-46
Stenner, K. Courtenay, M & Cannons K. (2011) Nurse prescribing for in-patient pain in
the United Kingdom: a national questionnaire survey. International Journal of
Nursing Studies, 48 (7), 847-855
Nurse prescribing introduced in many countries as a way to improve access to medication and service efficiency
As of International Council of Nurses, 2009 (CIE) – Prescribing defined as: ‘The act of determining what medication the patient should have and the correct dosage and duration of treatment’ (ICN, 2009) – for us, legal right to issue prescription for medication rather than supplying or dispensing medicines.
Jamaica – not legal yet Spain – was in process of legalising NP in 2008
At least 2 good reasons for this:
a) Prescribing is part of an extended role rather than an intervention or role in its own right. This makes it difficult to isolate where benefits are due to prescribing alone.
b) There are many variations in the way prescribing roles are configured within clinical teams which makes it difficult to compare models of care – it is difficult to identify a viable control group